Arsénico

1 Matschullat J. Arsenic in the geosphere—a review. The Science of the Total Environment 2000;249:297–312.

2 Gebel T. Confounding variables in the environmental toxicology of arsenic. Toxicology 2000;144:155–62.

3 Zaw M, Emett MT. Arsenic removal from water using advanced oxidation processes. Toxicol Lett 2002;133:113–18.

4 Lewis DR, Southwick JW, Ouellet Hellstrom R, et al. Drinking water arsenic in Utah: a cohort mortality study. Environ Health Perspect 1999;107:359–65.

5 Chowdhury UK, Biswas BK, Chowdhury TR, et al. Groundwater arsenic contamination in Bangladesh and West Bengal, India. Environ Health Perspect 2000;108:393–7.

6 Nickson R, McArthur J, Burgess W, et al. Arsenic poisoning of Bangladesh groundwater. Nature 1998;395:338–9.

7 British Geological Survey and Mott MacDonald Ltd (UK). Groundwater studies for arsenic contamination in Bangladesh, phase I: rapid investigation phase. Main report summary, 1999: S1–10.

8 Mukherjee AB, Bhattacharya P. Arsenic in ground water in the Bengal Delta Plain: slow poisoning in Bangladesh. Environ Rev 2001;9:189–220.

9 Guha Mazumder DN, Haque R, Ghosh N, et al. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol 1998;27:871–7.

10 Regelson W, Kim U, Ospina J, et al. Hemangioendothelial sarcoma of liver from chronic arsenic intoxication by Fowler’s solution. Cancer 1968;21:514–22.

11 Lander JJ, Stanley RJ, Sumner HW, et al. Angiosarcoma of the liver associated with Fowler’s solution (potassium arsenite). Gastroenterology 1975;68:1582–6.

12 Neshiwat LF, Friedland ML, Schorr-Lesnick B, et al. Hepatic angiosarcoma. Am J Med 1992;93:219–22.

13 Prystowsky SD, Elfenbein GJ, Lamberg SI. Nasopharyngeal carcinoma associated with long-term arsenic ingestion. Arch Dermatol 1978;114:602–3.

14 Shen ZX, Chen GQ, Ni JH, et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997;89:3354–60.

15 Bergstrom SK, Gillan E, Quinn JJ, et al. Arsenic trioxide in the treatment of a patient with multiply recurrent, ATRA-resistant promyelocytic leukemia: a case report. J Pediatr Hematol Oncol 1998;20:545–7.

16 Soignet SL, Maslak P, Wang ZG, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 1998;339:1341–8.

17 Fenaux P. Chomienne C. Degos L. Treatment of acute promyelocytic leukaemia. Clin Haematol 2001;14:153–74.

18 Zhu J, Chen Z, Lallemand-Breitenbach V, et al. How acute promyelocytic leukaemia revived arsenic. Nat Rev Cancer 2002;2:705–13.

19 Lorenzo HK, Susin SA, Penninger J, et al. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ 1999;6:516–24.

20 Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999;397:441–6.

21 Wong SS, Tan KC, Goh CL. Cutaneous manifestations of chronic arsenicism: review of seventeen cases. J Am Acad Dermatol 1998;38(2 pt 1):179–85.

22 Ko RJ. Causes, epidemiology, and clinical evaluation of suspected herbal poisoning. Clin Toxicol 1999;37:697–708.

23 Shen ZY, Tan LJ, Cai WJ, et al. Arsenic trioxide induces apoptosis of oesophageal carcinoma in vitro. Int J Mol Med 1999;4:33–7.

24 Kew J, Morris C, Aihie A, et al. Arsenic and mercury intoxication due to Indian ethnic remedies. BMJ 1993;306:506–7.

25 Treleaven J, Meller S, Farmer P, et al. Arsenic and Ayurveda. Leuk Lymphoma 1993;10:343–5.

26 Mitchell-Heggs CA, Conway M, Cassar J. Herbal medicine as a cause of combined lead and arsenic poisoning. Hum Exp Toxicol 1990;9:195–6.

27 Ong ES, Yong YL, Woo SO. Determination of arsenic in traditional Chinese medicine by microwave digestion with flow injection-inductively coupled plasma mass spectrometry (FI-ICP-MS). J AOAC Int 1999;82:963–7.Box 4: Key references

28 Wong ST, Chan HL, Teo SK. The spectrum of cutaneous and internal malignancies in chronic arsenic toxicity. Singapore Med J 1998;39:171–3.

29 Cobo JM, Castineira M. Oxidative stress, mitochondrial respiration, and glycemic control: clues from chronic supplementation with Cr3+ or As3+ to male Wistar rats. Nutrition 1997;13:965–70.

30 Abernathy CO, Liu YP, Longfellow D, et al. Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect 1999;107:593–7.

31 Edmonds JS, Francesconi KA. Transformations of arsenic in the marine environment. Experimentia 1987;43:553–7.

32 Buchet JP, Lison D, Ruggeri M, et al. Assessment of exposure to inorganic arsenic, a human carcinogen, due to the consumption of seafood. Arch Toxicol 1996;70:773–8.

33 Han B, Jeng WL, Chen RY, et al. Estimation of target hazard quotients and potential health risks for metals by consumption of seafood in Taiwan. Arch Environ Contam Toxicol 1998;35:711–20.

34 Thomas KW, Pellizzari ED, Berry MR. Population-based dietary intakes and tap water concentrations for selected elements in the EPA region V. National Human Exposure Assessment Survey (NHEXAS). J Expo Anal Environ Epidemiol 1999;9:402–13.

35 Tripathi RM, Raghunath R, Krishnamoorthy TM. Arsenic intake by the adult population in Bombay city. Sci Total Environ 1997;208:89–95.

36 Tamaki S, Frankenberger WT Jr. Environmental biochemistry of arsenic. Rev Environ Contam Toxicol 1992;124:79–110.

37 Gonzalez MJ, Aguilar MV, Martinez MC. Mechanisms of absorption of As2O5 from rat small intestine: the effect of different parameters. J Trace Elem Med Biol 1997;11:239–47.

38 Silver S, Misra TK. Bacterial transformations of and resistances to heavy metals. Basic Life Sci 1984;28:23–46.

39 Ratnaike RN, Barbour AH. Maldigestion and malabsorption. In: Ratnaike RN, ed. Small bowel disorders. London: Edward Arnold, 2000:302–15.

40 Thompson DJ. A chemical hypothesis for arsenic methylation in mammals. Chem Biol Interact 1993;88:89–114.

41 Aposhian HV. Enzymatic methylation of arsenic species and other approaches to arsenic toxicity. Ann Rev Pharmacol Toxicol 1997;37:397–419.

42 Hopenhayen-Rich C, Smith AH, Goeden HM. Human studies do not support the methylation threshold hypothesis of for the toxicity of inorganic arsenic. Environ Res 1993;60:161–77.

43 Benramdane L, Accominotti M, Fanton L, et al. Arsenic speciation in human organs following fatal arsenic trioxide poisoning—a case report. Clin Chem 1999;45:301–6.

44 Kingston RL, Hall S, Sioris L. Clinical observations and medical outcomes in 149 cases of arsenate ant killer ingestion. J Toxicol Clin Toxicol 1993;31:581–91.

45 Schoolmeester WL, White DR. Arsenic poisoning. South Med J 1980;73:198–208.

46 Opresko DM. Risk Assessment Information System database, Oak Ridge Reservation Environmental Restoration Program, 1992 (available at: http://risk.lsd.ornl.gov/tox/profiles/arseni_c.shtml).

47 Ghariani M, Adrien ML, Raucoules M, et al. Subacute arsenic poisoning. Ann Fr Anesth Reanim 1991;10:304–7.

48 Logemann E, Krutzfeldt B, Pollak S. Suicidal administration of elemental arsenic. Arch Kriminol 1990;185:80–8.